• Bioengineering in action

    Bioengineering in action

Investors and partners

Commercialisation partners

Polynerve is now interested in talking to commercialisation partners with a view to taking this bioengineered approach for nerve repair to market, ideally via licensing.

I consent to UMI3 Ltd collecting my name and email address. You can unsubscribe at any time by emailing ‘Unsubscribe’ to info@umip.com

This form collects your name, email address and your enquiry details so that we can effectively respond to your query. Please see our Privacy Policy on how we protect and manage your data.